Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

    • Autoimmune Disorder
    • Multiple Sclerosis (MS)
    • Relapsing-Remitting Multiple Sclerosis (RRMS)